Simplifying mealtime diabetes management for adults with type 1 diabetes using new medications and technology.
Official title: Alleviating carbohydrate counting in adults with type 1 diabetes with weekly Semaglutide injections added to an automated insulin delivery with Lyumjev
Funded at Mcgill University Health Ctr Res Inst · NIH-10917039 · Data updated 2026-11-12
This study is looking for ways to make life easier for adults with type 1 diabetes by testing a new method that combines weekly injections of Semaglutide with a smart insulin delivery system, so you can worry less about counting carbs at meals while still keeping your blood sugar in check.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mcgill University Health Ctr Res Inst NIH-funded |
| Lab location | 1 site (Montreal, Canada) |
| Project start | September 1, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $156,218 |
| NIH project number | 5R01DK135765-02 |
| Project ID | NIH-10917039 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who have been diagnosed with type 1 diabetes.
✕Less likely to help
Patients who do not have type 1 diabetes or those who are not able to participate in clinical trials may not benefit from this research.
What this research studies
This research investigates how to make managing diabetes easier for adults with type 1 diabetes by combining weekly Semaglutide injections with an automated insulin delivery system using Lyumjev. The goal is to reduce the burden of carbohydrate counting at mealtimes, which can be challenging for many individuals. By using GLP-1 receptor agonists and a faster-acting insulin, the study aims to improve blood glucose control without increasing the risk of low blood sugar. Participants will be monitored to assess the effectiveness of this combined approach in managing their diabetes.
Why it matters
Potential benefit: If successful, this research could significantly ease the daily management of diabetes for patients, leading to better blood sugar control and improved quality of life.
How similar studies have gone: Previous studies have shown that similar approaches using GLP-1 receptor agonists in type 2 diabetes have been successful, and recent data in type 1 diabetes also indicate promising results.
Where this research is happening
-
Mcgill University Health Ctr Res Inst
Montreal, Canada Active
Researchers
- Principal investigator: Tsoukas, Michael — Mcgill University Health Ctr Res Inst
- Study coordinator: Tsoukas, Michael
Related research
Other NIH-funded projects on the same topics.
-
Technological and Educational Approaches to Restore Hypoglycemia Awareness in Type 1 Diabetes
A two-arm study in adults with type 1 diabetes tests whether high-tech glucose control plus education or targeted training can help people regain awareness of low blood sugar.
-
Techniques for restoring awareness of low blood sugar in adults with type 1 diabetes
A randomized trial compares different approaches to help adults with type 1 diabetes recognize when their blood sugar is dipping so they can act quickly.
-
Treating impaired hypoglycemia awareness in type 1 diabetes with targeted education and technology
This study tests two treatment approaches to help adults with type 1 diabetes who often don’t realize their blood sugar is getting too low, using a mix of technology and education in two large groups.
-
Helping people with type 1 diabetes regain awareness of dangerous lows
A UK study tests two different approaches to help adults with type 1 diabetes recognize and respond to low blood sugar by comparing a high-tech insulin system with targeted education.
-
How the pancreas environment affects insulin-producing cells in type 1 diabetes
Researchers are studying how the surrounding tissue of the pancreas and its proteins influence insulin-producing cells in people with type 1 diabetes.
-
Understanding how hypoglycemia awareness changes in adults with type 1 diabetes and how automated insulin delivery and exercise might help restore it
This study will look at adults with type 1 diabetes to see how their awareness of low blood sugar evolves over time and whether automated insulin delivery and high-intensity exercise can help restore that awareness.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.